Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Terminated 2Completed 1

Sponsor Class

OTHER 8NETWORK 3INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Head and Neck Neoplasms 12Squamous Cell Carcinoma of Head and Neck 10Colorectal Neoplasms 10Rectal Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Lung Neoplasms 5Esophageal Neoplasms 4Colonic Neoplasms 4Adenocarcinoma of Lung 4Uterine Cervical Neoplasms 3Adenocarcinoma Of Esophagus 3Tongue Neoplasms 2Precancerous Conditions 2Papillomavirus Infections 2Pancreatic Neoplasms 2Esophageal Squamous Cell Carcinoma 2Anus Neoplasms 2Anal Canal Carcinoma 2Adenocarcinoma, Bronchiolo-Alveolar 2Radiation Injuries 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Hereditary Sensory and Autonomic Neuropathies 1Colorectal Cancer Metastatic 1Carcinoma, Ovarian Epithelial 1

Interventions

Fluorouracil 9Radiotherapy 8Cisplatin 7Paclitaxel 5Oxaliplatin 5Leucovorin 4Irinotecan 4Cetuximab 3Surgical Procedures, Operative 2Filgrastim 2Docetaxel 2uridine triacetate 1pegylated granulocyte colony-stimulating factor, human 1pegfilgrastim 1dehydroftorafur 1Sorafenib 1Radiation 1Polymerase Chain Reaction 1Platinum 1Granulocyte Colony-Stimulating Factor 1Gemcitabine 1Folfox protocol 1Drug Therapy 1Chemotherapy, Adjuvant 1Capecitabine 1Amplified Fragment Length Polymorphism Analysis 1AMG 337 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Adenocarcinoma Of Esophagus × Cetuximab × Clear all
NCT00551759 2023-07-03

Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer

Eastern Cooperative Oncology Group

Phase 2 Terminated
22 enrolled 5 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT00096031 2018-09-26

S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

SWOG Cancer Research Network

Phase 2 Completed
63 enrolled 9 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT00109850 2015-11-18

S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer

SWOG Cancer Research Network

Phase 2 Terminated
22 enrolled 9 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡